Skip to main content
Skip to section navigation
Skip to footer
Mineralys Therapeutics, Inc.
About
Team
Investor Relations
Publications
News
Careers
Contact
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Presentations
Email Alerts
SEC Filings
All SEC Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Filing Type:
View All
10-K
10-Q
144
3
4
424B4
8-A12B
8-K
CERT
CORRESP
D
DRS
DRS/A
EFFECT
S-1
S-1/A
S-1MEF
S-8
SC 13D
SC 13G
SEC STAFF LETTER
Year:
View All
2023
2022
Date
Form
Description
PDF
XBRL
Pages
03/21/23
4
Statement of changes in beneficial ownership of securities
1
03/15/23
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
expand_more
EX-4.3
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
145
03/15/23
8-K
Current report filing
Documents
expand_more
EX-99.1
8
02/24/23
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
6
02/24/23
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Documents
expand_more
EX-99
10
02/24/23
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Documents
expand_more
EX-99.1
10
02/16/23
4
Statement of changes in beneficial ownership of securities
1
02/16/23
4
Statement of changes in beneficial ownership of securities
3
02/16/23
4
Statement of changes in beneficial ownership of securities
2
02/16/23
4
Statement of changes in beneficial ownership of securities
1
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Next Page
arrow_forward
Email Alerts
Contacts
RSS News Feed